0.52Open0.38Pre Close1.95K Volume368 Open Interest83.00Strike Price104.34KTurnover649.92%IV0.70%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0974Delta0.3937Gamma4122.00Leverage Ratio-151.8209Theta0.0000Rho401.43Eff Leverage0.0001Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.